TABLE 1.
Demographic and clinical characteristics of study participants
| Demographics and clinical characteristics | Number (N = 30) | % |
|---|---|---|
| Current age (years) | ||
| 50–64 | 15 | 53 |
| 65–79 | 12 | 37 |
| 80+ | 3 | 10 |
| Time since RSV episode | ||
| 1 month | 10 | 33 |
| 2 months | 10 | 33 |
| 3 months | 5 | 17 |
| 6 months | 5 | 17 |
| Sex | ||
| Male | 15 | 50 |
| Female | 15 | 50 |
| Race/ethnicity | ||
| White | 13 | 43 |
| Other (American Indian or Alaska Native, Black/African American, Hispanic or Latino, Native Hawaiian/Other Pacific Islander) | 17 | 57 |
| Geographical location | ||
| USA—North | 4 | 13 |
| USA—South | 6 | 20 |
| USA—East | 6 | 20 |
| USA—West | 14 | 47 |
| Treatment setting | ||
| Outpatient (physician office, urgent care) | 22 | 73 |
| Hospital/emergency room | 8 | 27 |
| Diagnosis of comorbid condition a | ||
| Asthma | 6 | 20 |
| Chronic obstructive pulmonary disease | 9 | 30 |
| Congestive heart failure | 5 | 17 |
| Other (hypertension, emphysema, irritable bowel syndrome) | 2 | 7 |
| None | 12 | 40 |
Abbreviations: RSV, respiratory syncytial virus; USA, United States of America.
a
Participants reported multiple comorbid conditions.